Healx has new location at Chesterford Research Park
The lab will allow the Healx team to accelerate the discovery of potential new therapies for more rare conditions
Read More
Tag: Healx
Healx links with CTF to develop neurofibromatosis therapies
Cambridge, UK-based Healx has formed a new partnership with US and Europe-based patient group the Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF).
Read More
Healx, Boehringer link for rare neurological disease therapy
The project will utilise Healx’ AI-based drug discovery platform
Read More
Healx and Boston Children’s Hospital link up for Barth syndrome drug discovery
UK group Healx is to collaborate with Boston Children’s Hospital and Barth Syndrome Foundation for Barth syndrome.
Read More
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
